DrugPatentWatch Database Preview
Hisun Pharm Hangzhou Company Profile
What is the competitive landscape for HISUN PHARM HANGZHOU, and what generic and branded alternatives to HISUN PHARM HANGZHOU drugs are available?
HISUN PHARM HANGZHOU has eighteen approved drugs.
Summary for Hisun Pharm Hangzhou
| US Patents: | 0 |
| Tradenames: | 16 |
| Ingredients: | 16 |
| NDAs: | 18 |
Drugs and US Patents for Hisun Pharm Hangzhou
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hisun Pharm Hangzhou | IRBESARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; irbesartan | TABLET;ORAL | 207896-001 | Oct 14, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hisun Pharm Hangzhou | DAUNORUBICIN HYDROCHLORIDE | daunorubicin hydrochloride | INJECTABLE;INJECTION | 206195-001 | Apr 25, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
| Hisun Pharm Hangzhou | SIMVASTATIN | simvastatin | TABLET;ORAL | 206557-003 | Nov 13, 2017 | DISCN | No | No | Start Trial | Start Trial | |||||
| Hisun Pharm Hangzhou | TICAGRELOR | ticagrelor | TABLET;ORAL | 208575-001 | Jan 23, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hisun Pharm Hangzhou | DACTINOMYCIN | dactinomycin | INJECTABLE;INJECTION | 207232-001 | Jul 16, 2019 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Hisun Pharm Hangzhou | SIMVASTATIN | simvastatin | TABLET;ORAL | 206557-001 | Nov 13, 2017 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
